2Crespo J, Cayón A, Fernàndez-Gil P, Hernandez-Guerra M,Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, Pons-Romero F. Gene expression of tumor necrosis factor-α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.Hepatology 2001;34:1185-1163.
3Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzmàn M,Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidationvia protein kinase A. J Biol Chem 2001;276:25096-25100.
4Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Liddle C,Samarasinghe D, George J. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 2002;36:403-409.
5Gabriely I, Ma XH, Yang XM, Rossetti L, Barzilai N. Leptin resistance during aging is independent of fat mass. Diabetes 2002;51:1016-1021.
6Nakatani T, Tsuboyama-Kasaoka N, Takahashi M, Miura S,Ezaki O. Mechanism for peroxisome proliferator-activated re-ceptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes. J Biol Chem 2002;277:9562-9569.
7Huang X, Eriksson KF, Vaag A, Lehtovirta M, Hansson M,Laurila E, Kanninen T, Olesen BT, Kurucz I, Koranyi L, Groop L. Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes 1999;48:1508-1514.
8Patrick L. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 2002;7:276-301.
9Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.Nutr Rev 2002;60:289-303.
